In addition, a recent study on NSCLC patients showed that tumor-infiltrating NK cells express PD-1, as well as other inhibitory checkpoints, and that their dysfunction correlates with increasing levels of membrane PD-1 expression [43]. The gene discussed is PDCD1; the disease is neoplasm.